Loading viewer...
investor_presentation
Format: PDF investor_presentation
Proprietary Investor Presentation D.A. Davidson Big Sky T echnology Summit August 22, 2022
Investor Presentation
D.A. Davidson Big Sky T echnology Summit
Forward-Looking Statements, Non-GAAP Financials and COVID-19
This Presentation and the accompanying oral presentation include “forward ‐looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, regarding Ichor Holdings, Ltd. and its subsidiaries (“Ichor” or the “Company”), its financial condition, its results of
operations and the potential offering that reflect the Company’s current views and information currently available. This information is, where applicable, based on estimates,
assumptions and analysis that Ichor believes, as of the date hereof, provides a reasonable basis for the information contained herein. Forward ‐looking statements can generally be
identified by the use of forward ‐looking words such as “may”, “will”, “would”, could”, “expect”, “intend”, “plan”, “aim”, “estimate”, “target”, “anticipate”, “believe”, “continue”,
“objectives”, “outlook”, “guidance” or other similar words, and include statements regarding Ichor’s plans, strategies, initiatives, objectives, targets and future operating or financial
performance. These forward ‐looking statements involve known and unknown risks, uncertainties and other factors (including those set forth under “Risk Factors” in Ichor’s
prospectus), many of which are outside the control of Ichor and its representatives. Actual results, performance or achievements may differ materially and potentially adversely from
any projections and forward ‐looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the information contained
in this Presentation is reflective of future performance to any degree, and readers are cautioned not to place undue reliance on forward ‐looking statements as a predictor of future
performance. All information in this Presentation speaks only as of the date hereof unless otherwise specified. Ichor undertakes no duty to update or revise the information contained
herein, publicly or otherwise, whether as a result of new information, future events or otherwise. Forecasts and estimates regarding the Ichor’s industry and end-markets are based on
sources we believe to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.
This Presentation includes certain financial measures not presented in accordance with generally accepted accounting principles (“GAAP”), including, but not limited to, adjusted net
income from continuing operations and certain ratios and other metrics derived therefrom. These non ‐GAAP financial measures are not measures of financial performance in
accordance with GAAP and may exclude items that are significant in understanding and assessing Ichor’s financial results. Therefore, these measures should not be considered in
Preview truncated — download the full document for the complete content.
investor_presentation
21 Pages
investor_presentation
6 Pages
Pfizer